{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T21:49:09Z","timestamp":1769636949477,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Glycogen storage disease type Ib (GSD Ib) is a rare inborn error of glycogen metabolism due to mutations in <jats:italic>SLC37A4<\/jats:italic>. Besides a severe form of fasting intolerance, the disorder is usually associated with neutropenia and neutrophil dysfunction causing serious infections, inflammatory bowel disease, oral, urogenital and perianal lesions as well as impaired wound healing. Recently, SGLT2 inhibitors such as empagliflozin that reduce the plasma levels of 1,5-anhydroglucitol have been described as a new treatment option for the neutropenia and neutrophil dysfunction in patients with GSD Ib.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>We report on a 35-year-old female patient with GSD Ib who had been treated with G-CSF for neutropenia since the age of 9. She had a large chronic abdominal wound as a consequence of recurrent operations due to complications of her inflammatory bowel disease. Treatment with 20\u2009mg empagliflozin per day resulted in normalisation of the neutrophil count and neutrophil function even after termination of G-CSF. The chronic abdominal wound that had been unchanged for 2\u2009years before the start of empagliflozin nearly closed within 12\u2009weeks. No side effects of empagliflozin were observed.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>SGLT2 inhibitors are a new and probably safe treatment option for GSD Ib-associated neutropenia and neutrophil dysfunction. We hypothesize that restoration of neutrophil function and normalisation of neutrophil apoptosis leads to improvement of wound healing and ameliorates symptoms of inflammatory bowel disease.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13023-020-01503-8","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T14:03:06Z","timestamp":1598277786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-0468","authenticated-orcid":false,"given":"Sarah C.","family":"Gr\u00fcnert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Elling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e4rbel","family":"Maag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia B.","family":"Wortmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry G. J.","family":"Derks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Hannibal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"Schumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Rosenbaum-Fabian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Spiekerkoetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,24]]},"reference":[{"key":"1503_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0014-5793(97)01463-4","volume":"419","author":"I Gerin","year":"1997","unstructured":"Gerin I, Veiga-da-Cunha M, Achouri Y, Collet JF, Van Schaftingen E. Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib. FEBS Lett. 1997;419:235\u20138.","journal-title":"FEBS Lett"},{"key":"1503_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/08880018.2018.1440675","volume":"35","author":"AM Li","year":"2018","unstructured":"Li AM, Thyagu S, Maze D, Schreiber R, Sirrs S, Stockler-Ipsiroglu S, et al. Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length. Pediatr Hematol Oncol. 2018;35:45\u201351.","journal-title":"Pediatr Hematol Oncol"},{"key":"1503_CR3","first-page":"45","volume":"1","author":"MA Chen","year":"2016","unstructured":"Chen MA, Weinstein DA. Glycogen storage diseases: Diagnosis, treatment and outcome. Transl Sci Rare Dis. 2016;1:45\u201372.","journal-title":"Transl Sci Rare Dis"},{"key":"1503_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1067\/mpd.2000.105232","volume":"137","author":"G Visser","year":"2000","unstructured":"Visser G, Rake JP, Fernandes J, Labrune P, Leonard JV, Moses S, et al. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European study on glycogen storage disease type I. J Pediatr. 2000;137:187\u201391.","journal-title":"J Pediatr"},{"key":"1503_CR5","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1182\/blood-2013-05-502435","volume":"123","author":"HS Jun","year":"2014","unstructured":"Jun HS, Weinstein DA, Lee YM, Mansfield BC, Chou JY. Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib. Blood. 2014;123:2843\u201353.","journal-title":"Blood."},{"key":"1503_CR6","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.1182\/blood-2002-10-3128","volume":"101","author":"TW Kuijpers","year":"2003","unstructured":"Kuijpers TW, Maianski NA, Tool ATJ, Smit GPA, Rake JP, Roos D, et al. Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b). Blood. 2003;101:5021\u20134.","journal-title":"Blood."},{"key":"1503_CR7","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.1182\/blood-2007-12-129114","volume":"111","author":"SY Kim","year":"2008","unstructured":"Kim SY, Jun HS, Mead PA, Mansfield BC, Chou JY. Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib. Blood. 2008;111:5704\u201311.","journal-title":"Blood."},{"key":"1503_CR8","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nrendo.2010.189","volume":"6","author":"JY Chou","year":"2010","unstructured":"Chou JY, Jun HS, Mansfield BC. Glycogen storage disease type I and G6Pase-\u03b2 deficiency: etiology and therapy. Nat Rev Endocrinol. 2010;6:676\u201388.","journal-title":"Nat Rev Endocrinol"},{"key":"1503_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/MOH.0b013e328331df85","volume":"17","author":"JY Chou","year":"2010","unstructured":"Chou JY, Jun HS, Mansfield BC. Neutropenia in type Ib glycogen storage disease. Curr Opin Hematol. 2010;17:36\u201342.","journal-title":"Curr Opin Hematol"},{"key":"1503_CR10","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1073\/pnas.1816143116","volume":"116","author":"M Veiga-da-Cunha","year":"2019","unstructured":"Veiga-da-Cunha M, Chevalier N, Stephenne X, Defour J-P, Paczia N, Ferster A, et al. Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency. Proc Natl Acad Sci U S A. 2019;116:1241\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1503_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.bbrc.2016.11.075","volume":"482","author":"G-Y Kim","year":"2017","unstructured":"Kim G-Y, Lee YM, Kwon JH, Jun HS, Chou J. Glycogen storage disease type Ib neutrophils exhibit impaired cell adhesion and migration. Biochem Biophys Res Commun. 2017;482:569\u201374.","journal-title":"Biochem Biophys Res Commun"},{"key":"1503_CR12","doi-asserted-by":"publisher","unstructured":"Wortmann SB, Van Hove JLK, Derks TGJ, Chevalier N, Knight V, Koller A, et al. Treating neutropenia and neutrophil dysfunction in glycogen storage disease IB with an SGLT2-inhibitor. Blood. 2020;blood.2019004465. https:\/\/doi.org\/10.1182\/blood.2019004465. Online ahead of print.","DOI":"10.1182\/blood.2019004465"},{"key":"1503_CR13","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.2337\/dc13-0387","volume":"36","author":"RA DeFronzo","year":"2013","unstructured":"DeFronzo RA, Hompesch M, Kasichayanula S, Liu X, Hong Y, Pfister M, et al. Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes. Diabetes Care. 2013;36:3169\u201376.","journal-title":"Diabetes Care"},{"key":"1503_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cca.2015.11.010","volume":"452","author":"D Fortuna","year":"2016","unstructured":"Fortuna D, McCloskey LJ, Stickle DF. Model analysis of effect of canagliflozin (Invokana), a sodium-glucose cotransporter 2 inhibitor, to alter plasma 1,5-anhydroglucitol. Clin Chim Acta. 2016;452:138\u201341.","journal-title":"Clin Chim Acta"},{"key":"1503_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0022-1759(94)00247-T","volume":"178","author":"SJ Vowells","year":"1995","unstructured":"Vowells SJ, Sekhsaria S, Malech HL, Shalit M, Fleisher TA. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods. 1995;178:89\u201397.","journal-title":"J Immunol Methods"},{"key":"1503_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/MOH.0000000000000474","volume":"26","author":"DC Dale","year":"2019","unstructured":"Dale DC, Bolyard AA, Marrero T, Kelley ML, Makaryan V, Tran E, et al. Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor. Curr Opin Hematol. 2019;26:16\u201321.","journal-title":"Curr Opin Hematol"},{"key":"1503_CR17","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/00043426-200212000-00015","volume":"24","author":"M Pinsk","year":"2002","unstructured":"Pinsk M, Burzynski J, Yhap M, Fraser RB, Cummings B, Ste-Marie M. Acute myelogenous leukemia and glycogen storage disease 1b. J Pediatr Hematol Oncol. 2002;24:756\u20138.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1503_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/1752-1947-2-319","volume":"2","author":"T Schroeder","year":"2008","unstructured":"Schroeder T, Hildebrandt B, Mayatepek E, Germing U, Haas R. A patient with glycogen storage disease type Ib presenting with acute myeloid leukemia (AML) bearing monosomy 7 and translocation t(3;8)(q26;q24) after 14 years of treatment with granulocyte colony-stimulating factor (G-CSF): a case report. J Med Case Reports. 2008;2:319.","journal-title":"J Med Case Reports"},{"key":"1503_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.128","volume":"16","author":"PS Kishnani","year":"2014","unstructured":"Kishnani PS, Austin SL, Abdenur JE, Arn P, Bali DS, Boney A, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014;16:e1.","journal-title":"Genet Med"},{"key":"1503_CR20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1182\/blood.V97.2.376","volume":"97","author":"S Calderwood","year":"2001","unstructured":"Calderwood S, Kilpatrick L, Douglas SD, Freedman M, Smith-Whitley K, Rolland M, et al. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and\/or neutrophil dysfunction secondary to glycogen storage disease type 1b. Blood. 2001;97:376\u201382.","journal-title":"Blood."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01503-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01503-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01503-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:30:00Z","timestamp":1629765000000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01503-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,24]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1503"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01503-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,24]]},"assertion":[{"value":"17 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient gave her written informed consent for the publication of this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"218"}}